This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wildi, S. Articles by Korc, M. Search for Related Content PubMed PubMed Citation Articles by Wildi, S. Articles by Korc, M.

Characterization of Cytokeratin 20 Expression in Pancreatic and Colorectal Cancer¹

Departments of Medicine, Biological Chemistry, and Pharmacology [S. W., J. K., H. M., M. K.] and Department of Developmental and Cell Biology and Developmental Biology Center [A. D. L.], University of California, Irvine, California 92697, and Department of Visceral and Transplantation Surgery, University of Bern, 3010 Bern, Switzerland [C. A. M., H. F., M. W. B.]

Cytokeratin 20 belongs to the epithelial subgroup of the intermediate filament family. Because of its restricted range of expression in humans, it has become an important tool for detecting and identifying metastatic cancer cells by immunohistochemistry and by PCR analysis. Despite its widespread diagnostic use in colorectal cancer and occasional use in pancreatic cancer, little is known about the expression of CK 20 in these tumors in vivo. Therefore, in the present study we characterized CK 20 expression in pancreatic and colorectal cancer by comparison with its expression in the normal pancreas and colon. Tissue samples from 24 patients with pancreatic cancer and from 41 patients with colorectal cancer were examined for CK 20 expression by Northern blot analysis, immunohistochemistry, and in situ hybridization. CK 20 expression was observed in the cancer cells of both cancer types. A subgroup of the pancreatic cancers exhibited a 3.2-fold increase in CK 20 mRNA by comparison with respective normal controls. In contrast, colon cancers underexpressed CK 20 mRNA by comparison with the respective controls. In the normal tissues, CK 20 immunoreactivity was relatively faint and sparse in the pancreatic ductal cells but intense and abundant in the apical portions of the colonic mucosa. CK 20 immunoreactivity was also evident in the ductal cells from the chronic pancreatitis-like lesions adjacent to the cancer cells. Furthermore, distant metastases from pancreas carcinomas exhibited strong CK 20 immunoreactivity. It is concluded that CK 20 is overexpressed in pancreatic cancer and that it can serve as an excellent marker for metastatic pancreatic cancer.

This article has been cited by other articles:

				C. W. M. Chan, N. A. Wong, Y. Liu, D. Bicknell, H. Turley, L. Hollins, C. J. Miller, J. L. Wilding, and W. F. Bodmer Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1 PNAS, February 10, 2009; 106(6): 1936 - 1941. [Abstract] [Full Text] [PDF]

				O. Wada-Hiraike, O. Imamov, H. Hiraike, K. Hultenby, T. Schwend, Y. Omoto, M. Warner, and J.-A. Gustafsson Role of estrogen receptor beta in colonic epithelium PNAS, February 21, 2006; 103(8): 2959 - 2964. [Abstract] [Full Text] [PDF]

				L. Zhu, T. Tran, J. M. Rukstalis, P. Sun, B. Damsz, and S. F. Konieczny Inhibition of Mist1 Homodimer Formation Induces Pancreatic Acinar-to-Ductal Metaplasia Mol. Cell. Biol., April 1, 2004; 24(7): 2673 - 2681. [Abstract] [Full Text] [PDF]

				K. Fukahi, M. Fukasawa, G. Neufeld, J. Itakura, and M. Korc Aberrant Expression of Neuropilin-1 and -2 in Human Pancreatic Cancer Cells Clin. Cancer Res., January 15, 2004; 10(2): 581 - 590. [Abstract] [Full Text] [PDF]

				F A Vlems, J H S Diepstra, I M H A Cornelissen, T J M Ruers, M J L Ligtenberg, C J A Punt, J H J M van Krieken, T. Wobbes, and G N P van Muijen Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue Mol. Pathol., June 1, 2002; 55(3): 156 - 163. [Abstract] [Full Text] [PDF]

				C. L. Pin, J. M. Rukstalis, C. Johnson, and S. F. Konieczny The bHLH transcription factor Mist1 is required to maintain exocrine pancreas cell organization and acinar cell identity J. Cell Biol., November 12, 2001; 155(4): 519 - 530. [Abstract] [Full Text] [PDF]